Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3591-3600 of 10862

Edit search filters
  1. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab

    Rochester, MN

  2. A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

    Rochester, MN

  3. Gastric Alimetry In Predicting and Assessing of Gut-Directed Hypnotherapy for Patients with Gastroduodenal DGBIS

    Rochester, MN

  4. Weight Loss Through Mayo Clinic Diet

    Rochester, MN

  5. CNS Tumors With Latent Residual Disease To Guide Individualized Therapies

    Rochester, MN

  6. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

    Jacksonville, FL

  8. Carboplatin and Gemcitabine Hydrochloride With or Without VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  9. Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

  10. Lu AF82422 in participants with Multiple System Atrophy

    Rochester, MN

.

Mayo Clinic Footer